You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-PCSK9 antibody (ab28770)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab28770? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab28770 has been referenced in 3 publications.

  1. Liu M et al. PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain. J Lipid Res 51:2611-8 (2010). PubMed: 20453200
  2. Lambert G et al. Plasma PCSK9 Concentrations Correlate with LDL and Total Cholesterol in Diabetic Patients and Are Decreased by Fenofibrate Treatment. Clin Chem : (2008). WB; Human. PubMed: 18436719
  3. Blesa S et al. A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia. J Clin Endocrinol Metab 93:3577-83 (2008). WB; Human. PubMed: 18559913

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"